Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121749773 | 12174977 | 3 | F | 201511 | 20160719 | 20160314 | 20160727 | EXP | US-GLAXOSMITHKLINE-US2016033295 | GLAXOSMITHKLINE | 70.00 | YR | F | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121749773 | 12174977 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK UNK, BID | 21077 | INHALATION POWDER | BID | ||||||||
121749773 | 12174977 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), BID | UNKNOWN | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
121749773 | 12174977 | 3 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 2 MG, TID | UNKNOWN | 0 | 2 | MG | TABLET | TID | |||||
121749773 | 12174977 | 4 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
121749773 | 12174977 | 5 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
121749773 | 12174977 | 6 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 2 PUFF(S), PRN | 0 | 2 | DF | |||||||||
121749773 | 12174977 | 7 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
121749773 | 12174977 | 8 | SS | REQUIP XL | ROPINIROLE HYDROCHLORIDE | 1 | 2 MG, QD | U | UNKNOWN | 0 | 2 | MG | PROLONGED-RELEASE TABLET | QD | |||||
121749773 | 12174977 | 9 | C | CARBIDOPA. | CARBIDOPA | 1 | U | 0 | |||||||||||
121749773 | 12174977 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
121749773 | 12174977 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
121749773 | 12174977 | 12 | C | KLONOPIN | CLONAZEPAM | 1 | U | 0 | |||||||||||
121749773 | 12174977 | 13 | C | LOVASTATIN. | LOVASTATIN | 1 | U | 0 | |||||||||||
121749773 | 12174977 | 14 | C | TIZANIDINE. | TIZANIDINE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121749773 | 12174977 | 1 | Chronic obstructive pulmonary disease |
121749773 | 12174977 | 2 | Emphysema |
121749773 | 12174977 | 3 | Parkinson's disease |
121749773 | 12174977 | 4 | Restless legs syndrome |
121749773 | 12174977 | 5 | Essential tremor |
121749773 | 12174977 | 6 | Chronic obstructive pulmonary disease |
121749773 | 12174977 | 7 | Emphysema |
121749773 | 12174977 | 8 | Restless legs syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121749773 | 12174977 | OT |
121749773 | 12174977 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121749773 | 12174977 | Asthenia | |
121749773 | 12174977 | Back injury | |
121749773 | 12174977 | Bladder catheterisation | |
121749773 | 12174977 | Bronchitis | |
121749773 | 12174977 | Cystitis | |
121749773 | 12174977 | Emphysema | |
121749773 | 12174977 | Fall | |
121749773 | 12174977 | Hip arthroplasty | |
121749773 | 12174977 | Hyperhidrosis | |
121749773 | 12174977 | Knee arthroplasty | |
121749773 | 12174977 | Lip blister | |
121749773 | 12174977 | Memory impairment | |
121749773 | 12174977 | Muscle spasms | |
121749773 | 12174977 | Nausea | |
121749773 | 12174977 | Oral mucosal blistering | |
121749773 | 12174977 | Spinal operation | |
121749773 | 12174977 | Vertebral osteophyte |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121749773 | 12174977 | 8 | 201606 | 0 |